MarketPeel
Insider Trading Intelligence
JJ

Jerome D. Jabbour

MTNB
PRESIDENT AND CEO · MATINAS BIOPHARMA HOLDINGS, INC. · CIK 0001698838
FILING MIX · LIFETIME92%/8%
BUYS
12
SELLS
1
TOTAL VALUE
$6.5K
COMPANIES
2
ACTIVE SINCE
Jun 2019
HOLDINGS NOW
95,100
AVG SELL PX
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Jerome D. Jabbour, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+1.59%-3.26%+4.85%+4.85%
14d1+0.00%-9.74%+2.56%-12.30%-12.30%
30d1+100.00%+2.17%+11.05%-8.89%-8.89%
60d1+100.00%+14.87%+13.91%+0.96%+0.96%
90d1+100.00%+24.11%+22.17%+1.93%+1.93%
180d1+100.00%+8.24%+35.27%-27.02%-27.02%
1y1+100.00%+74.44%+60.08%+14.35%+14.35%
2y1+0.00%-11.58%+80.11%-91.69%-91.69%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MTNB · 70,100 shares · as of Apr 30, 2025
0497,075994,1501,491,2251,988,300202020212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 12 buys / 1 sellsCOVERAGE · 28 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INDP
INDAPTUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Feb 26, 2026Feb 27, 2026View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
70,10070,100Apr 30, 2025May 2, 2025View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,988,3001,988,300Dec 20, 2022Dec 22, 2022View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,658,1001,658,100Dec 14, 2021Dec 15, 2021View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
SALE
President and CEO
150Jun 19, 2021Jun 24, 2021View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASE
President and CEO
6,000810,011Jun 19, 2021Jun 24, 2021View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASE
President and CEO
30,000840,011Jun 19, 2021Jun 24, 2021View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,600,0001,600,000Jan 1, 2021Jan 4, 2021View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASE
President and CEO
4,500804,011Jun 23, 2020Jun 24, 2020View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
500,000500,000Jun 17, 2020Jun 19, 2020View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASE
President and CEO
10,000$0.65$6.5K799,511Mar 17, 2020Mar 18, 2020View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,000,0001,000,000Jan 1, 2020Jan 3, 2020View →
MTNB
MATINAS BIOPHARMA HOLDINGS, INC.
PURCHASE
President and CEO
3,000789,511Jun 21, 2019Jan 3, 2020View →
Other insiders · MTNB
Loading peer insiders…
About this filer
CIK 0001698838
ROLE
President and CEO
PRIMARY
MTNB
COMPANIES
2
ACTIVE SINCE
Jun 2019
MARKETPEEL · /INSIDER/0001698838DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback